Research is being conducted on the role of immune checkpoint inhibitors in cancer therapy, exploring their mechanisms and potential therapeutic advances. The therapy's application is being studied in various types of cancer, including bladder cancer and non-small cell lung cancer. Additionally, investigations are underway to understand how factors such as the microbiome and platelets interact with immune checkpoint inhibitors, as well as how to overcome resistance to the therapy.